ResearcherTongji UniversityActive in the last 2 years
Yongkun Wang
Matched on ORCID iD 0000-0001-5705-8674; OpenAlex author ID A5101883503. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 7
- Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. Co-author DOI 10.1016/j.canlet.2025.217583↗
- Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1568976↗
- The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway. Co-author DOI 10.4149/neo_2023_230614n310↗
- LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Co-author DOI 10.1016/j.omtn.2021.07.004↗
- The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/aging.102835↗
- The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133… Co-author DOI 10.1080/15384101.2018.1496741↗
- Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer. Co-author DOI 10.1007/s11033-013-2766-1↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ran Cui · 4 shared papers, 2021–2025 · strength 0.83
- Paper Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer. DOI 10.3389/fimmu.2025.1568976↗
- Paper Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. DOI 10.1016/j.canlet.2025.217583↗
- Paper The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway. DOI 10.4149/neo_2023_230614n310↗
- Bo Chen · 3 shared papers, 2023–2025 · strength 0.70
- Paper Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer. DOI 10.3389/fimmu.2025.1568976↗
- Paper Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. DOI 10.1016/j.canlet.2025.217583↗
- Paper The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway. DOI 10.4149/neo_2023_230614n310↗
- Xiaohua Jiang · 2 shared papers, 2018–2025 · strength 0.32
- Paper Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. DOI 10.1016/j.canlet.2025.217583↗
- Paper The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF… DOI 10.1080/15384101.2018.1496741↗
- Xiaohua Jiang · 1 shared paper, 2025 · strength 0.27
- Bo Chen · 2 shared papers, 2020–2021 · strength 0.25
- Xiaohua Jiang · 1 shared paper, 2023 · strength 0.19
- Ming Xu · 1 shared paper, 2021 · strength 0.13
- Jianying Tang · 1 shared paper, 2020 · strength 0.13
- Yongping Zhou · 1 shared paper, 2018 · strength 0.08
- Bo Chen · 1 shared paper, 2018 · strength 0.08
- Wujun Xiong · 1 shared paper, 2018 · strength 0.08
- Hui Zhang · 1 shared paper, 2013 · strength 0.04
- Congjun Wang · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.